发明名称 SUBSTITUTED PHENYL AMIDINES AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
摘要 1478671 N - (substituted phenyl) - amidines SCHERICO Ltd 17 June 1974 [20 June 1973] 26773/74 Heading C2C Novel compounds and their acid addition salts I in which M is [where R<SP>1</SP> is H, C 1-6 alkyl, C 3-6 cycloalkyl, OH, C 1-6 alkoxy, C 3-6 cycloalkoxy or phenyl (optionally substituted by NO 2 , CF 3 or Hal), R<SP>2</SP> is H, C 1-6 alkyl or C 3-6 cycloalkyl or R<SP>1</SP> and R<SP>2</SP> together are C 3-7 alkylene or -(CH 2 ) 2# (CH 2 ) 2 - (where #is >O, >S, >NH or >N C 1-6 alkyl) and R<SP>8</SP> is H or C 1-6 alkyl], X is N0 2 , CF 3 , Cl, Br or I, Y is H, Hal, NO 2 , amino optionally mono- or di-C 1-6 alkylated, C 1-6 alkyl, C 1-6 alkoxy, polyfluoro C 1-6 alkoxy, polyfluoro C 1-6 alkyl, polyfluoro C 1-6 alkylthio, NR<SP>3</SP>COR<SP>5</SP> or NR<SP>3</SP>SO 2 R<SP>4</SP> (where R<SP>3</SP> is H or C 1-6 alkyl, R<SP>4</SP> is C 1-6 alkyl, aralkyl or aryl and R<SP>5</SP> is C 1-6 alkoxy, aralkoxy, aryloxy, C 1-6 alkyl, aralkyl or aryl), R is a divalent alkane or alkene radical in which at least one C atom has more than two C atoms bonded to it and any double bond in the alkene moiety is not conjugated with the amidine group and Z is H, OH, C 1-6 alkoxy, aryl C 1-6 alkoxy, C 1-6 alkanoyloxy, aryl C 1-6 alkanoyloxy carbamoyloxy or thiocarbamoyloxy both optionally mono- or di-C 1-6 alkylated with the proviso that when X is Cl, Br or I at least one of R1, R<SP>2</SP>, R<SP>8</SP> or Z is other than H are prepared by (1) reacting a compound II in which A- is an anion, Q<SP>4</SP> is Hal or an alkoxy or aralkoxy radical and Z is as above other than hydroxy with an appropriate amine R<SP>1</SP>R<SP>2</SP>NH to form a compound I (Z # OH); (2) condensing an aniline IV or a reactive derivative thereof with an appropriate imidate or the corresponding free base, in which Q<SP>2</SP> is Hal, alkoxy or alkylthio to form a compound I (Z # OH); (3) condensing an amide or thioamide X=C(NR<SP>1</SP>R<SP>2</SP>)-R-Z (where X is O or S) with an appropriate amine VI or a reactive derivative thereof or an amide or thio amide VIII with an appropriate amine R<SP>1</SP>R<SP>2</SP>NH or reactive derivative thereof to produce a compound I (Z # OH); (4) the Beckmann rearrangement of a compound X in which T is an acyl radical in the presence of an amine R<SP>1</SP>R<SP>2</SP>NH to form a compound I [M = -N=C(NR<SP>1</SP>R<SP>2</SP>)-]; (5) reacting an amine VI or a salt thereof with a nitrile Z-R-CN optionally in the presence of compounds capable in a manner known per se of introducing groups R<SP>1</SP>a and R<SP>2</SP>a, where R<SP>1</SP>a is C 1-6 alkyl, C 3-6 cycloalkyl or phenyl (optionally substituted by NO 2 , CF 3 or Hal), R<SP>2</SP>a is C 1-6 alkyl or C 3-6 cycloalkyl or R<SP>1</SP>a and R<SP>2</SP>a are as defined for R<SP>1</SP> and R<SP>2</SP> together to form a compound I (R<SP>1</SP> = H or R<SP>1</SP>a, R<SP>2</SP> = H or R<SP>2</SP>a); (6) converting X=NH 2 to X=C1, Br or I using the Sendmeyer reaction in compounds I (Y is other than amino) ; (7) eliminating NH2 from a compound equivalent to a compound I. (except that Y is not amino) and containing such a group; (8) reducing a compound XV in which Q<SP>5</SP> is a double bond conjugated with the amidine double bond to form a compound I (R = alkylene; Z = H); (9) hydrolysing a compound XIX to form a compound I (Z = OH); (10) alkylating a compound I (M = to replace the N-hydrogen atom with C 1-6 alkyl ; (11) alkylating a compound I (R<SP>1</SP> = H, OH and/or R<SP>2</SP> = H) to give a compound I (B<SP>1</SP> = C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkoxy or C 3-6 cycloalkoxy and/or R2 = C 1-6 alkyl or C 1-6 cycloalkyl); (12) converting Y = NH 2 to mono- or di-C 1-6 alkylamino, halogen or NR<SP>3</SP>COR<SP>5</SP> (where R<SP>3</SP> is H or C 1-6 alkyl, R<SP>5</SP> is C 1-6 alkyl, aralkyl (or aryl) by methods known per se in compounds I; (13) hydrolysing Y = acylamino or reducing Y=NO 2 to NH 2 in compounds I; (14) subjecting a compound I (Z = C 1-6 alkoxy or aryl C 1-6 alkoxy) to ether cleavage to produce compounds I (Z = OH); (15) acylating or etherifying a compound I (Z=OH) to form a compound I (Z = C 1-6 alkoxy, aryl C 1-6 alkoxy- C 1-6 alkanoyloxy, aryl-C 1-6 alkanoyloxy or di- C 1-6 alkylcarbamoyloxy; (16) reducing an alkenyline group R to the corresponding alkylene group; or (17) forming a salt by salification of a compound I. Compounds I are anti-androgenic agents and form with a carrier or excipient a pharmaceutical or veterinary composition which may be administered orally, parenterally or rectally. They may also be admixed with animal feedstuff.
申请公布号 PH12364(A) 申请公布日期 1979.01.29
申请号 PH19580000159 申请日期 1974.06.18
申请人 SCHERICO LTD 发明人 GOLD E
分类号 C07D295/12;C07C67/00;C07C239/00;C07C257/18;C07C259/14;C07C275/70;C07C301/00;C07C303/40;C07C311/00;C07C311/13;C07C311/21;C07C313/00;C07C323/41;C07D295/195 主分类号 C07D295/12
代理机构 代理人
主权项
地址